Yes, you should increase your Lantus dose
With a fasting blood glucose of 166 mg/dL (9.2 mmol/L) on Lantus 10 units, you need to titrate up your dose using a structured algorithm to reach your target fasting glucose without hypoglycemia.
Evidence-Based Titration Approach
The current guidelines and FDA labeling provide clear direction for your situation 1, 2:
Standard Titration Algorithm
Increase your Lantus by 2 units every 3 days until you reach your fasting plasma glucose (FPG) goal 1. This is the evidence-based approach recommended in the 2025 ADA Standards of Care.
Specifically, based on your current FBG of 166 mg/dL:
- Your FBG is ≥180 mg/dL equivalent range
- Increase by 6-8 units immediately, then continue titrating by 2 units every 3 days 1
- If you experience any blood glucose <70 mg/dL (3.9 mmol/L), hold the increase and reduce dose by 10-20% 1
Target Fasting Glucose
Your FPG goal should be <100 mg/dL (5.6 mmol/L) to achieve an HbA1c <7% 1, 3. Recent high-quality evidence from 2019-2021 demonstrates that:
- An optimal FBG target of 3.9-6.1 mmol/L (70-110 mg/dL) achieves the best HbA1c outcomes without significantly increasing hypoglycemia risk 3
- Patients achieving FPG ≤6.1 mmol/L were significantly more likely to reach HbA1c <7% compared to those with FPG >6.1 mmol/L 4, 3
- The 6.1 mmol/L (110 mg/dL) target also resulted in better glycemic variability control 5
Practical Implementation
Titration Schedule
- Week 1: Increase from 10 to 16-18 units (given your FBG is very elevated)
- Ongoing: Check FBG daily and increase by 2 units every 3 days if FBG remains >100 mg/dL
- Stop increasing when FBG consistently reaches 70-110 mg/dL range
Safety Monitoring
- Check your blood glucose if you feel symptoms of hypoglycemia (shakiness, sweating, confusion)
- If any reading is <70 mg/dL, reduce your dose by 10-20% 1
- Continue monitoring FBG daily during titration
Important Caveats
Do not delay titration. Therapeutic inertia is a major problem in diabetes management 1. Your current FBG of 166 mg/dL indicates significant undertreatment.
Patient-managed titration is effective and safe. A large trial (AT.LANTUS) with nearly 5,000 patients showed that patient-managed dose adjustments (increasing 2 units every 3 days) achieved better HbA1c reduction than clinic-managed titration, with only slightly higher hypoglycemia rates that remained clinically acceptable 6.
Timing flexibility: Lantus can be given at any time of day, but must be at the same time each day 2, 7. Morning or bedtime dosing shows equivalent efficacy and hypoglycemia risk 7.
This assumes you have type 2 diabetes. If you have type 1 diabetes, you must also be on mealtime rapid-acting insulin 2.